Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 28 resultados

VICT3R: Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research VICT3R, a public-private partnership running under the European Innovative Health Initiative, aims to significantly reduce the number of ani...
2024-07-26 - 2028-02-29 | Financiado

RESPIRE-EXCEL: Respiratory Precision Medicine PhD Training Network Excellence through Systems Biology Spatial and... ASTRAZENECA UK LIMITED participó en un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 Asthma and COPD are prevalent, chronic respiratory diseases, with high incidence and societal costs. Current treatment is based on a ‘one-si...
2024-07-01 - 2029-02-28 | Financiado

BonePainIII: Identifying mechanisms and novel treatments of bone pain – closing the gap to the clinic. ASTRAZENECA UK LIMITED participó en un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 Musculoskeletal pain from diseases such as arthritis and cancer in the bone affects the quality of life of millions and is a major societal...
2023-07-14 - 2027-12-31 | Financiado

GUIDE.MRD: GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD ASTRAZENECA UK LIMITED participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage Advancing personalized approaches in cancer therapy, aiding identification and adaptation of multi-modal treatment strategies for improved o...
2023-05-17 - 2028-04-30 | Financiado

Maxima Butterfly: From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network ASTRAZENECA UK LIMITED participó en un HORIZON EUROPE: HORIZON-MSCA-2021-COFUND-01 Every year, around 600 children in the Netherlands get cancer and one in four children dies from this illness. More than ten years ago, a gr...
2022-10-10 - 2027-12-31 | Financiado

ISOBIOTICS: Isotopic Labeling of Biotherapeutics ASTRAZENECA UK LIMITED participó en un HORIZON EUROPE: HORIZON-MSCA-2021-DN-01 Biological drugs such as peptides, proteins, oligonucleotides and analogs provide the patients with more efficacious and less toxic treatmen...
2022-07-14 - 2027-01-31 | Financiado

BiocatCodeExpander: Genetic code expansion for biocatalysis and enzyme engineering doctoral network ASTRAZENECA UK LIMITED participó en un HORIZON EUROPE: HORIZON-MSCA-2021-DN-01 The expansion of the genetic code for the incorporation of non-canonical amino acids (NCAA) in proteins provides biotechnologists with an am...
2022-07-06 - 2026-12-31 | Financiado

ETERNAL: Boosting the reduction of the environmental impact of pharmaceutical products throughout their entir... ASTRAZENECA UK LIMITED participó en un HORIZON EUROPE: HORIZON-HLTH-2021-IND-07 ETERNAL aims to contribute to sustainable development of pharmaceutical manufacture, use and disposal, by using and promoting full life cycl...
2022-05-23 - 2026-08-31 | Financiado

EndoConnect: EU Training Network in understanding the molecular regulation and the role of endo lysosomal process... ASTRAZENECA UK LIMITED participó en un H2020: H2020-MSCA-ITN-2020 The endo-lysosomal system is essential to acquire lipids and nutrients according to the need of the cell and, subsequently, to maintain meta...
2020-09-03 - 2025-03-31 | Financiado

PRECODE: PancREatic Cancer OrganoiDs rEsearch Network ASTRAZENECA UK LIMITED participó en un H2020: H2020-MSCA-ITN-2019 The PRECODE Network (PancREatic Cancer OrganoiDs rEsearch) central mission is to establish pancreatic organoid research firmly in the Europe...
2019-08-12 - 2024-03-31 | Financiado

EUROoC: Interdisciplinary training network for advancing Organ on a chip technology in Europe ASTRAZENECA UK LIMITED participó en un H2020: H2020-MSCA-ITN-2018 EUROoC will create a trans-European network of industrially oriented specialists fully trained in development and application of the emergin...
2018-08-21 - 2023-05-31 | Financiado

BonePainII: A European Training Network to Combat Bone Pain ASTRAZENECA UK LIMITED participó en un H2020: H2020-MSCA-ITN-2018 In Europe 20 - 30% of adults are affected at any one time by musculoskeletal pain such as arthritic pain, lower back pain, pain from osteopo...
2018-08-20 - 2022-12-31 | Financiado

QuanTII: Quantitative T cell Immunology and Immunotherapy ASTRAZENECA UK LIMITED participó en un H2020: H2020-MSCA-ITN-2017 Health and disease are regulated, to a large extent, by our immune system. The immune system not only protects the body from infectious dise...
2018-05-18 - 2023-08-31 | Financiado

BigMedilytics: Big Data for Medical Analytics ASTRAZENECA UK LIMITED participó en un H2020: H2020-ICT-2016-2017 There are three main reasons for an immediate innovation action to apply big data technologies in Healthcare. Firstly, a Healthy nation is a...
2017-11-21 - 2021-09-30 | Financiado

NoMADS: Nonlocal Methods for Arbitrary Data Sources ASTRAZENECA UK LIMITED participó en un H2020: H2020-MSCA-RISE-2017 In NoMADS we focus on data processing and analysis techniques which can feature potentially very complex, nonlocal, relationships within the...
2017-11-08 - 2023-08-31 | Financiado

LightDyNAmics: DNA as a training platform for photodynamic processes in soft materials ASTRAZENECA UK LIMITED participó en un H2020: H2020-MSCA-ITN-2017 Light interaction with biomaterials is the driving mechanism of fundamental biological processes, from photosynthesis to DNA photodamage, an...
2017-08-29 - 2022-10-31 | Financiado

EI3POD: EMBL Interdisciplinary International and Intersectorial Postdocs The EIPOD programme was developed in 2007 with the objective of making use of the excellent scientific environment available at EMBL to supp...
2015-05-13 - 2020-11-30 | Financiado

F³ FACTORY: Flexible Fast and Future Production Processes ASTRAZENECA UK LIMITED participó en un FP7: The F3 consortium’s vision is that the EU’s chemical industry’s competitive position would be strongly enhanced if it could operate modular...
Financiado

SYNFLOW: Innovative Synthesis in Continuous Flow Processes for Sustainable Chemical Production ASTRAZENECA UK LIMITED participó en un FP7: The SYNFLOW vision is the paradigm shift from batch-wise large volume processes in pharmaceuticals, fine chemicals and intermediates product...
Financiado

CASYM: Coordinating Action Systems Medicine Implementation of Systems Medicine across Europe ASTRAZENECA UK LIMITED participó en un FP7: The aim of CASyM is a combined large scale effort to sustainably implement Systems Medicine across Europe. For that purpose CASyM will funct...
Financiado